UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (213) 213
life sciences & biomedicine (209) 209
oncology (192) 192
humans (177) 177
male (107) 107
female (106) 106
middle aged (101) 101
aged (87) 87
lung neoplasms - drug therapy (85) 85
adult (78) 78
carcinoma, non-small-cell lung - drug therapy (75) 75
respiratory system (64) 64
lung neoplasms - pathology (54) 54
lung neoplasms - genetics (53) 53
aged, 80 and over (49) 49
carcinoma, non-small-cell lung - genetics (49) 49
lung cancer (43) 43
protein kinase inhibitors - therapeutic use (40) 40
antineoplastic agents - therapeutic use (39) 39
carcinoma, non-small-cell lung - pathology (34) 34
lung cancer, non-small cell (33) 33
mutation (33) 33
treatment outcome (33) 33
crizotinib (32) 32
pulmonary and respiratory medicine (29) 29
care and treatment (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
cancer (25) 25
disease-free survival (25) 25
antineoplastic agents - adverse effects (24) 24
gene rearrangement (24) 24
neoplasm staging (24) 24
pyrazoles - therapeutic use (24) 24
pyridines - therapeutic use (24) 24
abridged index medicus (23) 23
chemotherapy (23) 23
non-small cell lung cancer (23) 23
hematology, oncology and palliative medicine (22) 22
neoplasms - drug therapy (22) 22
nsclc (22) 22
lung neoplasms - mortality (21) 21
metastasis (21) 21
retrospective studies (21) 21
lung neoplasms - enzymology (20) 20
prognosis (20) 20
brain neoplasms - secondary (19) 19
carcinoma, non-small-cell lung - mortality (19) 19
receptor protein-tyrosine kinases - genetics (19) 19
research (19) 19
analysis (18) 18
lung neoplasms - metabolism (18) 18
patients (18) 18
protein kinase inhibitors - adverse effects (18) 18
young adult (18) 18
alk (16) 16
cancer therapies (16) 16
carcinoma, non-small-cell lung - enzymology (16) 16
non-small cell lung carcinoma (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
drug resistance, neoplasm - genetics (15) 15
follow-up studies (15) 15
general & internal medicine (15) 15
survival rate (15) 15
tumors (15) 15
anaplastic lymphoma kinase (14) 14
animals (14) 14
disease progression (14) 14
genetic aspects (14) 14
kaplan-meier estimate (14) 14
maximum tolerated dose (14) 14
proto-oncogene proteins - genetics (14) 14
receptor protein-tyrosine kinases - antagonists & inhibitors (14) 14
antineoplastic agents - administration & dosage (13) 13
protein kinase inhibitors - administration & dosage (13) 13
receptor, epidermal growth factor - genetics (13) 13
carcinoma, non-small-cell lung - secondary (12) 12
medicine, general & internal (12) 12
non–small cell lung cancer (12) 12
proto-oncogene proteins c-met - genetics (12) 12
antineoplastic agents - pharmacology (11) 11
clinical trials as topic (11) 11
dose-response relationship, drug (11) 11
health aspects (11) 11
protein-tyrosine kinases - antagonists & inhibitors (11) 11
protein-tyrosine kinases - genetics (11) 11
solid tumors (11) 11
adenocarcinoma - drug therapy (10) 10
carboplatin - administration & dosage (10) 10
carcinoma, non-small-cell lung - metabolism (10) 10
egfr (10) 10
erbb receptors - genetics (10) 10
in situ hybridization, fluorescence (10) 10
lung neoplasms - diagnosis (10) 10
protein kinase inhibitors - pharmacology (10) 10
pyrazoles - adverse effects (10) 10
receptor, epidermal growth factor - antagonists & inhibitors (10) 10
survival analysis (10) 10
tyrosine (10) 10
adenocarcinoma - genetics (9) 9
cancer research (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 234 - 242
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2011, Volume 12, Issue 11, pp. 1004 - 1012
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 9, pp. 829 - 838
Alectinib, a potent ALK tyrosine kinase inhibitor, was more effective and somewhat less toxic than crizotinib when used as primary therapy in patients with ALK... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Central Nervous System Neoplasms - secondary | Young Adult | Pyridines - adverse effects | Anaplastic Lymphoma Kinase | Antineoplastic Agents - adverse effects | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Receptor Protein-Tyrosine Kinases - analysis | Pyrazoles - adverse effects | Pyridines - therapeutic use | Crizotinib | Carbazoles - adverse effects | Kaplan-Meier Estimate | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Animals | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Intention to Treat Analysis | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Central Nervous System Neoplasms - drug therapy | Drugs | Care and treatment | Analysis | Comparative analysis | Lung cancer, Non-small cell | Health aspects | Systemic diseases | Toxicity | Lung cancer | Central nervous system | Non-small cell lung carcinoma | Oncology | Nervous system | Metastasis | Radiation therapy | Patients | Lymphoma | Cancer therapies | Survival | Mutation | Protein-tyrosine kinase | Drug dosages | Tumors | Index Medicus | Abridged Index Medicus
Journal Article